Delayed sleep-wake phase disorder and shift work...Delayed Sleep-Wake Phase Disorder • There is a...
Transcript of Delayed sleep-wake phase disorder and shift work...Delayed Sleep-Wake Phase Disorder • There is a...
© Associated Professional Sleep Societies, LLC 1
Delayed sleep-wake phase disorder and shift work
James K. Wyatt, Ph.D., D. ABSM, FAASMDirector, Section of Sleep Disorders and Sleep-Wake Research
Rush University Medical CenterAssociate Professor of Behavioral Sciences
Rush Medical College
© Associated Professional Sleep Societies, LLC 2
Conflict of Interest Disclosures for SpeakersX 1. I do not have any relationships with any entities producing, marketing, re-
selling, or distributing health care goods or services consumed by, or used on, patients, OR
2. I have the following relationships with entities producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Type of Potential Conflict Details of Potential Conflict
Grant/Research Support
Consultant
Speakers’ Bureaus
Financial support
Other
3. The material presented in this lecture has no relationship with any of these potential conflicts, OR
4. This talk presents material that is related to one or more of these potential conflicts, and the following objective references are provided as support for this lecture:
1.
2.
3.
© Associated Professional Sleep Societies, LLC 3
• We have very few “BEST” practices for treating the pediatric circadian rhythm disorders
• …more research is needed…
CONCLUSION
© Associated Professional Sleep Societies, LLC 4
By the end of this presentation, learners will be able to:
• describe circadian and homeostatic modulation of sleep to patients, and implement interventions for insomnia symptoms based on these complaints
• implement cognitive-behavioral treatment components for DSPD and shift work disorder
Educational Objectives
© Associated Professional Sleep Societies, LLC 5
Recommended reading(in addition to the ICSD-3)
• Auger RR et al. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015. JCSM. 2015 11(10)1199-1236
• Morgenthaler TI et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep. 2007 Nov 1;30(11):1445-59.
• Sack RL et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep. 2007 Nov 1;30(11):1460-83.
• Sack RL et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep. 2007 Nov 1;30(11):1484-501.
© Associated Professional Sleep Societies, LLC 6
SLEEP HOMEOSTASIS
• During each hour you are awake (“cost” of being awake): – Sleep-promoting substances build up in the
brain (e.g. adenosine)– Wake-promoting substances are used up in
the brain (e.g., NE, 5-HT)• During sleep
– Sleep-promoting substances are cleared– Wake-promoting substances are replenished
© Associated Professional Sleep Societies, LLC 7
INTRINSIC CIRCADIAN TIMEKEEPING SYSTEM
• 24-hour clock in the brain• Suprachiasmatic nucleus (the “SCN”)• Biological day vs. biological night• Regulates timing of (for example):
– Core body temperature– Appetite– Amount of urine production– Alertness / sleepiness
• Coordinates clocks throughout the body
© Associated Professional Sleep Societies, LLC 8
2-PROCESS MODEL OF SLEEP-WAKE REGULATION (aka, a 4-person relay race)
Borbély, Hum Neurobiol, 1982; Borbély et al model, HFSP, 2000
© Associated Professional Sleep Societies, LLC 9
12pmWT
12amBT
8amWT
CROSSOVER
ZONE
Minimal Shifting Effect for
Midday Light
PhaseDelay
(move later)
Evening /Early Night
Light
PhaseAdvance
(move earlier)
Early morning /After wake time
12pmWT
© Wyatt, 2013Stable sleep‐wake schedule =Stable light‐dark schedule =Optimal entrained circadian phase
NORMALSLEEPERS
© Associated Professional Sleep Societies, LLC 10
PHOTOTHERAPY DURING SLEEP
• 2msec flash• 3,000 lux• (eyes closed,
so around 300 lux)
• Every 30 sec• From 2-3hr
after bedtime• 30 min
phase delay
Zeitzer JM et al, 2014, JBR
© Associated Professional Sleep Societies, LLC 11
Evening reading: 4 hours of pre-bedtime iPad vs. book
Change A‐M et al, 2015, PNAS
© Associated Professional Sleep Societies, LLC 12
“Real life trumps laboratory inmatters of public health”
• That is, the light emitted from the eReaders would have had a much smaller effect in alerting the brain than they would have had the participants been exposed to a normal pattern of everyday light exposure before using the eReaders before bedtime. Thus, the question still remains as to whether the light being emitted from an eReader, or any other type of electronic device, would actually impact nocturnal alertness and sleep in normally behaving individuals.
Zeitzer JM, 2015, PNAS
Change A‐M et al, 2015, PNAS
“Reply to Zeitzer: Good science, in or out of the laboratory, should prevail”
© Associated Professional Sleep Societies, LLC 13
12pmWT
12amBT
8amWT
CROSSOVER
ZONE
PhaseAdvance
(move earlier)
Late Afternoon/Early Evening
MEL
PhaseDelay
(move later)
Late night /Early morning
PHASE RESPONSE CURVE for EXOGENOUS MELATONIN(The “Melatonin PRC”)
12pmWT
© Wyatt, 2008Melatonin PRC, see: Lewy, et al, Chronobiol. Int., 1998; Burgess et al., J Physiol, 2008
NOTE: Clock times denote only to habitual sleep schedule for sample patient, not to absolute clock time for all
© Associated Professional Sleep Societies, LLC 14
MELATONIN AS A CIRCADIAN PHASE-DEPENDENT HYPNOTIC
Wyatt et al., Sleep, 2006
© Associated Professional Sleep Societies, LLC 15
MORNING LIGHT + AFTERNOON MELATONIN IN 18-40yo GOOD SLEEPERS
• 0.5mg melatonin 5hr prior to BT
• Sleep schedule 1hr earlier/day
• 2hr = 30min on/off• 1hr = 15min on/off• 0.5hr = 30min at WT
• 1.8hr phase advance in 0.5hr group
Crowley & Eastman, 2015, Sleep Medicine
© Associated Professional Sleep Societies, LLC 16
HOMEOSTATIC IMPLICATIONS FOR CIRCADIAN SLEEP
DISORDERS• Naps
– Decrease homeostatic drive– Delays sleep onset, lighter sleep– Good for shift work and jet lag (+ short daytime sleep)– Bad for DSPD (need the homeostatic drive for SOL)
• Late wake times– Shorter duration of subsequent wake– Lower homeostatic drive for sleep initiation and
consolidation (DSPD on weekends)• Shorter sleep duration
– EDS, fatigue, cognitive and mood dysfunction– DSPD on weekdays, shift workers at night
© Associated Professional Sleep Societies, LLC 17
CAFFEINETHE GOOD:• 3-7 hr half life• Adenosine receptor antagonist (adenosine builds during
wake)• Attenuates the expression of sleep homeostatic
pressure• Good for homeostatic-related (not circadian) cognitive
deficits with extended wakefulness1 (jet lag, shift work)
THE BAD:• May increase sleep latency2
• Suppresses slow wave activity (deep sleep) 3
• “sensitivity”: insomnia, nervousness, irritability, tachycardia
1 Wyatt, et al, Sleep, 20042 Landolt, et al, Neuropsychopharmacology, 19953 Landolt, et al, Brain Res., 1995
© Associated Professional Sleep Societies, LLC 18
ICSD-3: CIRCADIAN RHYTHM SLEEP-WAKE DISORDERS
© Associated Professional Sleep Societies, LLC 19
General Criteria for Circadian Rhythm Sleep-Wake Disorder
• A chronic or recurrent pattern of sleep-wake rhythm disruption due primarily to an alteration of the circadian timing system or to a misalignment between the internal circadian rhythm and the sleep-wake schedule desired or required by an individual’s physical environment or social/work schedules.
• The circadian rhythm disruption leads to insomnia symptoms, excessive sleepiness, or both.
• The sleep and wake disturbances cause clinically significant distress or impairment in mental, physical, social, occupational, educational, or other important areas of functioning.
ICSD‐3
© Associated Professional Sleep Societies, LLC 20
ASSESSMENT TOOLS
• Sleep diary– Required for most
• Wrist actigraphy– Strongly encouraged
• Chronotype assessment– May be helpful
• Circadian phase assessment (CBT, DLMO, aMT6s)– On the horizon
© Associated Professional Sleep Societies, LLC 21
DLMOFIGURE FROM: Lewy & Sack, Neuropsychopharmacology, 2002
© Associated Professional Sleep Societies, LLC 22
HOME DLMO ASSESSMENT• N=35, 21-62yo good sleepers
– (DSPD paper under review)• HOME/LAB or LAB/HOME, 5 days, then
opposite order• 6hrs prior to mean BT until 2hrs after• Every 30 minutes• Detailed orientation• Cotton in compliance-monitoring container• Light meter to ensure dim light
Burgess et al, Sleep, 2015
© Associated Professional Sleep Societies, LLC 23
• 10 minute difference on average
Burgess et al, Sleep, 2015
© Associated Professional Sleep Societies, LLC 24
• Munich Chronotype Questionnaire• Morningness Eveningness Questionnaire• Age• Vs. DLMO• 36 controls, 24 DSPD• “4hr range in the DLMO was observed at a
given (questionnaire) score”• Chronotype score NOT TO BE USED to time
treatments
CHRONOTYPE VS. DLMOKantermann, Sung, & Burgess 2015, JBR
© Associated Professional Sleep Societies, LLC 25
Delayed Sleep-Wake Phase Disorder
• There is a delay in the phase of the major sleep episode in relation to the desired or required sleep time and wake-up time, as evidenced by a chronic or recurrent complaint by patient or caregiver of inability to fall asleep and difficulty awakening at a desired or required clock time.
• The symptoms are present for at least three months.• When patients are allowed to choose their ad libitum schedule, they
will exhibit improved sleep quality and duration for age and maintain a delayed phase of the 24-hour sleep-wake pattern.
• Sleep log and, whenever possible, actigraphy monitoring for at least seven days (preferably 14 days) demonstrates a delay in the timing of the habitual sleep period. Both work/school days and free days must be included within this monitoring.
• Not better explained by another current sleep disorder, medical or neurological disorder, mental disorder, medication use, or substance use disorder.
ICSD‐3
© Associated Professional Sleep Societies, LLC 26
ASSOCIATED FEATURES
• DSPD and evening types– Higher rates of psychiatric disorders– E.g., mood disorders, suicide risk
• Potential overlap/alternation with free running disorder
• KEY POINT: can develop conditioned (or other) insomnia over time – both may require treatment
ICSD‐3
© Associated Professional Sleep Societies, LLC 27
PREVALENCE OF DSPD• 374 Australian teens• Sleep diary + actigraphy + questionnaires• DSPD: 1%• 1 ICSD2 criterion: 52%• 2 ICSD2 criteria: 14%• 0 ICSD2 criteria: 33%
• Differentiation of evening type vs. delayed phase vs. delayed sleep vs. DSPD
Lovato et al., 2013, JCSM
© Associated Professional Sleep Societies, LLC 28
DSPD Subtype: motivated delayed sleep phase disorder
• “a subgroup typically comprised of adolescents who have little intrinsic motivation to successfully complete treatment and thereby resume a “normal” lifestyle (regular school attendance, developmentally appropriate peer interactions, etc).”
• Psychiatric comorbidity is high• Factors to avoid school (e.g., learning disability)• Exaggerated parental response of “inability to
awaken” with extreme measures
ICSD‐3
© Associated Professional Sleep Societies, LLC 29
WHAT ABOUT HAVING THIS SLEEP PROBLEM IS:
BAD NEUTRAL GOOD
DECISIONAL BALANCE
© Associated Professional Sleep Societies, LLC 30
DSPD vs. ADHD
• N=9,846 (age 16-19) in Norway• Higher vs. lower ADHD symptoms:
– Increased risk of DSPD (7.6% vs. 2.8%)– Increased insomnia (33.7% vs. 11.4%)
• Possible bidirectional relationship between impaired sleep and ADHD
• Suggest targeting sleep in ADHD diagnosis and treatment
Hysing et al., BSM 2015 Oct, 1‐15
© Associated Professional Sleep Societies, LLC 31
POOR ACADEMIC PERFORMANCE IN DSPD
Siversten et al., Sleep Med. 2015;16(9):1084‐90
© Associated Professional Sleep Societies, LLC 32
Shift Work Disorder• There is a report of insomnia and/or excessive sleepiness,
accompanied by a reduction of total sleep time, which is associated with a recurring work schedule that overlaps the usual time for sleep.
• The symptoms have been present and associated with the shift work schedule for at least three months.
• Sleep log and actigraphy monitoring (whenever possible and preferably with concurrent light exposure measurement) for at least 14 days (work and free days) demonstrates disturbed sleep and wake pattern.
• The sleep and/or wake disturbance are not better explained by another current sleep disorder, medical or neurological disorder, mental disorder, medication use, poor sleep hygiene, or substance use disorder.
© Associated Professional Sleep Societies, LLC 33
INSOMNIA IN SHIFT WORKERS
• N = 1,586 nurses in Norway• Evening shift insomnia
– Higher in 2-shift and 3-shift rotation: 29.8% vs 19.8%
• Night shift insomnia– Higher in 3-shift than only night workers: 67.7%
vs 41.7%• Off-night insomnia
– permanent night workers 11.4% – 2-shift rotators: 4.2%– 3-shift rotators: 3.6%
Flo et al., Occup Environ Med 2013; 70(4):238‐45
© Associated Professional Sleep Societies, LLC 34
CHRONOTYPE vs. SHIFT WORK
• Old thought: evening types did better at shift work
• Higher use of hypnotics in evening-type shift workers (Futenma et al., Sleep Medicine 2015: 16(5):604-11)
• Worse sleep quality (Yazdi et al., Work 2014; 47(4):561-7)
• Worse sleep on day and night shifts (Martin et al., Chronobiol Int 2015; 32(5):627-36)
• TAKE HOME: Don’t be an evening chronotype and engage in shift work
© Associated Professional Sleep Societies, LLC 35
SAFETY RISKS OF HYPNOTIC USE
• Increased risk with multiple hypnotics• 6.9% single hypnotic, 3.1% multiple
hypnotics• Only SWSD predicted multiple hypnotic use
(OR 2.8)
Futenma et al., Sleep Medicine 2015: 604‐11
© Associated Professional Sleep Societies, LLC 36
PARASOMNIAS in ROTATING SHIFT WORKERS
• N = 2,198 nurses in Norway• Higher confusional arousals
– (vs. day only: day/evening: OR 2.10 and day/evening/night: OR 1.71)
• Nightmares– (vs. day only: day/evening: OR 1.64 and
day/evening/night: OR 1.57)• Only night shift = no change in parasomnia
incidence
Bjorvatn et al., Chronobiol Int 2015; 32(10):1352‐8
© Associated Professional Sleep Societies, LLC 37
TREATMENT OPTIONS: APPLICATIONS FOR DSPD
© Associated Professional Sleep Societies, LLC 38
UPDATE FROM 2015 (Auger et al.)ASWPD: The TF suggests that clinicians treat adult ASWPD patients with
evening light therapy (versus no treatment). [WEAK FOR]N24SWD The TF suggests that clinicians use strategically timed melatonin for the treatment of N24SWD in blind adults (versus no treatment). [WEAK FOR]DSPD
• The TF suggests that clinicians treat DSWPD in adults with and without depression with strategically timed melatonin (versus no treatment). [WEAK FOR]
• The TF suggests that clinicians treat children and adolescents with DSWPD (and no comorbidities) with strategically timed melatonin (versus no treatment). [WEAK FOR]
• The TF suggests that clinicians treat children and adolescents with DSWPD comorbid with psychiatric conditions with strategically timed melatonin (versus no treatment). [WEAK FOR]
• The TF suggests that clinicians treat children and adolescents with DSWPD with post-awakening light therapy in conjunction with behavioral treatments (versus no treatment). [WEAK FOR]
© Associated Professional Sleep Societies, LLC 39
ISWRD • The TF suggests that clinicians treat ISWRD in elderly patients with
dementia with light therapy (versus no treatment). [WEAK FOR]• The TF recommends that clinicians avoid the use of sleep-promoting
medications to treat demented elderly patients with ISWRD (versus no treatment). [STRONG AGAINST]
• The TF suggests that clinicians avoid the use of melatonin as a treatment for ISWRD in older people with dementia (versus no treatment). [WEAK AGAINST]
• The TF suggests that clinicians use strategically timed melatonin as a treatment for ISWRD in children/adolescents with neurologic disorders (versus no treatment). [WEAK FOR]
• The TF suggests that clinicians avoid the use of combined treatments consisting of light therapy in combination with melatonin in demented, elderly patients with ISWRD (versus no treatment). [WEAK AGAINST]
2015 UPDATE: CONTINUED
© Associated Professional Sleep Societies, LLC 40
CRSD TREATMENT OPTIONS1 Identify the homeostatic and circadian contributions to sleep/wake complaints2 Fight the EDS• Caffeine (not great for children)• Stimulants / “Alerting Agents” (not great for children)• Prevent or encourage napping
3 Put you to sleep• Melatonin / melatonin agonists• Hypnotics (not great for children)
4 Shift circadian phase• Melatonin• Phototherapy• Sleep scheduling (e.g., chronotherapy, naps, no naps)
© Associated Professional Sleep Societies, LLC 41
PATIENT EDUCATION POINTS:DSPD Example
• Naps lower homeostatic drive, hence SO insomnia– Example: afterschool naps, then SO insomnia
• Late wake time, then early bedtime– Shorter duration of sustained wakefulness– Insufficient homeostatic drive to fall asleep– Example: Sunday night insomnia
• Late sleep onset, then early wake time– Shorter duration of sleep– Higher EDS from leftover homeostatic sleep drive– Example: school nights
© Associated Professional Sleep Societies, LLC 42
SLEEP SCHEDULING
• When to sleep and when not to sleep
• Chronotherapy – progressive shift of S-W schedule (DSPD, ASPD)
• Enforcing a daily S-W cycle vs. patient’s ad lib schedule (free-running, irregular)
• Major sleep episode with scheduled napping (jet lag, shift work)
© Associated Professional Sleep Societies, LLC 43
CHRONOTHERAPY [indicated: option for DSPD]
12pm 12am12am
Pre 1Pre 2Pre 3Day 1Day 2Day 3Day 4Day 5Day 6Day 7Post 1Post 2Post 3
3am 6am 9am 3pm 6pm 9pm
BASELINE / STABILIZATION
3hr DELAY OF BT/WT SCHEDULE
RIGID ADHERENCE TO SLEEP SCHEDULE
SMALLER SHIFT IF REQUIRED
Post 4
© Wyatt, 2008
modified from Czeisler et al., Sleep, 1982NOTE: Clock times denote only to habitual sleep schedule for sample patient, not to absolute clock time for all
© Associated Professional Sleep Societies, LLC 44
• Need to advance phase to an earlier hour• Light exposure in the “morning” (see PRC)
– natural light, artificial bright light
• NO STANDARD PROTOCOL; I suggest:– stabilize S-W schedule x 3 days– start 60+ min. light, starting at late wake time– dose of 2,000-10,000 lux– 30 min. per day advance of BT/WT schedule– 30 min. per day advance of light onset– *** dim light in the evening (prevent phase delay)– 30 min. maintenance dose of light at wake time– evaluation by ophthalmologist if ? ocular risk
PHOTOTHERAPY[indicated: guideline for DPSD]
Wyatt, Sleep Medicine Clinics, 2007DS
PD
© Associated Professional Sleep Societies, LLC 45
St Hilaire et al., J Physiol, 20101hr light pulse =• ~ 30 min phase advance• 1+ hr phase delay
© Associated Professional Sleep Societies, LLC 46
PHOTOTHERAPY[indicated: guideline]
12pm 12am12am
Pre 1Pre 2Pre 3Day 1Day 2Day 3Day 4Day 5Day 6Day 7Day 8Day 9Day 10
3am 6am 9am 3pm 6pm 9pm
BASELINE / STABILIZATION
1. 30min. ADVANCE OF BT/WT SCHEDULE PER DAY
2. 60min. BRIGHT LIGHT AT WT
3. 2hr DIM LIGHT PRIOR TO BT
STRICT SLEEP SCHEDULE30min. MAINTENANCE LIGHT
Post 1Post 2
Wyatt, Sleep Medicine Clinics, 2007
© Wyatt, 2008
NOTE: Clock times denote only to habitual sleep schedule for sample patient, not to absolute clock time for all
© Associated Professional Sleep Societies, LLC 47
3pmWT
3amBT
11amWT
CROSSOVER
ZONE
Minimal Shifting Effect for
Midday Light
PhaseDelay
(move later)
Evening /Early Night
Light
PhaseAdvance
(move earlier)
Early morning /After wake time
3pmWT
© Wyatt, 2013
RIDE
TO
SCHOOL
Morning light exposure occurs in the region of maximal phase delays for DSPD patientslikely MAINTAINING the phase delay
DSPDPATIENTS
© Associated Professional Sleep Societies, LLC 48
RCT: CBT + PHOTOTHERPY• Age 11-18, DSPD diagnosis• CBT (n=23)
– sleep education (Session 1)– heavy cognitive component (Sessions 2-5)– Wrap-up (Session 6)– 30-120 minutes of post-awakening light of 1,000
lux or sunlight– 30min phase advance of sleep schedule/day
• Wait list control (n=17)• Daily sleep diary• Wrist actigraphy: insufficient data
Gradisar et al., Sleep, 2011
DSPD
© Associated Professional Sleep Societies, LLC 49
RESULTS• School night sleep
– 56 minute decrease in sleep latency– 38 minute earlier sleep onset time– 60 minutes more total sleep time– 26 minute earlier wake-up time
• Some improvement in weekend sleep• Good maintenance of gain at 6 months• Improved EDS and fatigue
See also: Danielsson et al., 2015, BSM: RCT of CBT+Light: decreased anxiety and depression
Gradisar et al., Sleep, 2011
DSPD
© Associated Professional Sleep Societies, LLC 50
MELATONIN – phase shifting• Max phase advance: give 5 hr prior to DLMO1
– DLMO is ~1.5 to 2 hr. prior to BT
• Relapse reported as high after stopping in clinical trials– May have to be a chronic treatment
• ? if really just phase-dependent hypnotic effect• Sedation concern with afternoon (phase
advancing) or morning (phase delaying) dosing• Neuroendocrine concern for use in young children &
adolescents– Different risk : benefit evaluation with severe
neurodevelopmental disorders
1 Burgess et al., 2008, J Physiol
DSPD
© Associated Professional Sleep Societies, LLC 51
MELATONIN[indicated: guideline]
12pm12am
Pre 1Pre 2Pre 3Day 1Day 2Day 3Day 4Day 5Day 6Day 7Day 8Day 9Day 10
3am 6am 9am 3pm 6pm 9pm
BASELINE / STABILIZATION
1. 30min. ADVANCE OF BT/WT SCHEDULE PER DAY
2. MELATONIN 15-30min. PRIOR TO BT
3. 2hr DIM LIGHT PRIOR TO BT
1. STRICT SLEEP SCHEDULE2. MAINTAIN MELATONIN
Post 1Post 2
9pm
© Wyatt, 2008
NOTE: Clock times denote only to habitual sleep schedule for sample patient, not to absolute clock time for all
© Associated Professional Sleep Societies, LLC 52
MELATONIN FOR DSPD
• Meta-analysis of 9 suitable studies– 0.3-5 mg– Fixed time, time range, or X hours prior to
DLMO– Up to 4 weeks– n’s =8 to 105– Mix of sleep diary, actigraphy, PSG– Most measured DLMO
van Geijlswijk et al., Sleep, 2010
DSPD
© Associated Professional Sleep Societies, LLC 53
META-ANALYSIS RESULTS
• Adults• DLMO advanced 1.69 hours (1.13
hr/children)• Sleep onset time 0.7 hours (0.64 hr/children)• Wake-up time earlier in children only• Sleep latency shorter in only in children• Total sleep time increased only in children• Most studies didn’t advance dose timing
van Geijlswijk et al., Sleep, 2010
DSPD
© Associated Professional Sleep Societies, LLC 54
DSPD: PHOTOTHERAPY + MELATONIN
• N-40, age 16-25, DSPD• 2 weeks: DL+PLA, BL+PLA, DL+MEL,
BL+MEL• All: gradual advance of WT 1hr/day• 3 months open label, BL+MEL or no tx
• ALL GROUPS: advance of BT, WT, DLMO• High relapse rate with no treatment f/u• Good durability with long-term treatment
Saxvig et al., 2013, Chronobiol Intl; Wilhelmsen‐Langeland et al., 2013, JRB
DSPD
© Associated Professional Sleep Societies, LLC 55
SHIFT WORK• Nap during night or extended shifts [indicated:
standard]• Hypnotic for day sleep [indicated: guideline]
• Recovery sleep– rebound sleep, telephone & doorbell off, protected
sleep time (kids, pets)– catch up prior to next night shift
• Error detection systems, redundancy• Light exposure at work for stimulatory effect• Don’t work shifts
– some individuals are more intolerant of shift work
© Associated Professional Sleep Societies, LLC 56
THE END